Hideyuki Hayashi, Junichi Matsubara, Hiroshi Nishihara, Eishi Baba, Ichiro Kinoshita, Hirokazu Takami, Naohiro Nishida, Masahiro Tabata, Toru Mukohara, Masanobu Takahashi, Hirotsugu Kenmotsu, Satoshi Nishiwaki, Yayoi Ando, Kuniko Sunami, Tatsunori Shimoi, Noboru Yamamoto. "Phase II trial of trametinib in patients with advanced solid tumors harboring genomic alterations in the MAPK pathway: Results from the BELIEVE trial (NCCH1901).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3111